CXCL13 expression in Chlamydia trachomatis infection of the female reproductive tract.

King, M; Poya, H; Rao, J; Natarajan, S; Butch, A W; Aziz, N; Kok, S; Chang, M H; Lyons, J M; Ault, K; Kelly, K A

King, M; Poya, H; Rao, J; Natarajan, S; Butch, A W; Aziz, N; Kok, S; Chang, M H; Lyons, J M; Ault, K; Kelly, K A.

Affiliation

King M; Division of Neonatology, Department of Pediatrics, David Geffen UCLA Medical Center, Los Angeles, California, USA.

Drugs Today (Barc) ; 45 Suppl B: 125-34, 2009 Nov.

Article in En | MEDLINE | ID: mdl-20011704

Subject(s)

Chemokine CXCL13/physiology; Chlamydia Infections/etiology; Chlamydia trachomatis; Fallopian Tubes/microbiology; Salpingitis/etiology; Chemokine CXCL13/analysis; Chemokine CXCL13/genetics; Chlamydia Infections/immunology; Female; Humans; RNA, Messenger/analysis; Salpingitis/immunology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Salpingitis / Chlamydia Infections / Chlamydia trachomatis / Chemokine CXCL13 / Fallopian Tubes Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Drugs Today (Barc) Journal subject: MEDICINA OCUPACIONAL / SAUDE AMBIENTAL Year: 2009 Document type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google